Description

4-[(10R,13R,17R)-3,7-Dihydroxy-10,13-Dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-Tetradecahydro-1H-Cyclopenta[A]Phenanthren-17-Yl]Pentanoic Acid is a high-purity, steroidal carboxylic acid derivative of significant interest in advanced pharmaceutical research and synthesis. This compound serves as a critical chiral building block and intermediate for developing novel therapeutic agents, particularly in the fields of endocrinology and metabolic disease. It is essential for research institutions, pharmaceutical R&D laboratories, and fine chemical manufacturers engaged in the synthesis of complex bioactive molecules.

Application

• Pharmaceutical Intermediate: A key chiral synthon for the research and development of steroidal drugs and hormone analogs.
• Biochemical Research: Used as a reference standard or precursor in studies of steroid biosynthesis, metabolism, and receptor interactions.
• Fine Chemical Synthesis: Serves as a versatile building block for constructing complex molecular architectures in medicinal chemistry.
• Academic Research: Utilized in university and institutional labs for investigating new synthetic pathways and biological activities.
• Process Development: Employed in scaling up synthetic routes for potential Active Pharmaceutical Ingredients (APIs).
• Reference Material: Suitable for use as an analytical standard in quality control laboratories for method development and validation.

Basic Information

Product Name	4-[(10R,13R,17R)-3,7-Dihydroxy-10,13-Dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-Tetradecahydro-1H-Cyclopenta[A]Phenanthren-17-Yl]Pentanoic Acid
CAS No.	15357-34-3
Molecular Formula	C24H38O4
Molecular Weight	390.56 g/mol
Synonyms	3β,7β-Dihydroxy-5β-cholan-24-oic Acid; 3β,7β-Dihydroxy-5β-cholanic Acid; 7β-Hydroxylithocholic Acid; (3β,5β,7β)-3,7-Dihydroxycholan-24-oic Acid; 5β-Cholan-24-oic acid, 3,7-dihydroxy-, (3β,5β,7β)-; Norchenodeoxycholic acid derivative
EINECS	Contact for details

Quality Control

Our 4-[(10R,13R,17R)-3,7-Dihydroxy-10,13-Dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-Tetradecahydro-1H-Cyclopenta[A]Phenanthren-17-Yl]Pentanoic Acid is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC, NMR, and chiral purity analysis, to ensure identity, potency, and purity meet exacting standards for research use. Certificates of Analysis (COA) with detailed chromatographic data are available upon request.

Storage

Preserve in a tightly closed container, protected from light. Store at 2-8°C in a dry, cool environment. The product is hygroscopic (moisture-sensitive) and should be handled under inert atmosphere when appropriate for prolonged use.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Assay (HPLC)	≥97.0%
Chiral Purity	≥99.0% ee
Loss on Drying	≤1.0%
Residue on Ignition	≤0.1%
Heavy Metals	≤20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.